Ayala Pharmaceuticals Employee Directory

Ayala Pharmaceuticals corporate office is located in 4 Oppenheimer St, Rehovot, Central District, Israel and has 11-50 employees.

Employees by Department

Departments

Number of employees

Operations

4

Medical & Health

2

Engineering & Technical

2

C-Suite

2

Finance

1

Sales

1

Ayala Pharmaceuticals CEO

AL
Israel flag for contact location.
Anthony LombardoChief Executive Officer
PhonePhoneEmailEmail
See Profile

Key Employees of Ayala Pharmaceuticals

  • GH
    Israel flag for contact location.
    Gili Hart

    Chief Development Officer

    PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail
  • PhonePhoneEmailEmail

Ayala Pharmaceuticals Global Presence

globalPresence illustration
North America1-10
Asia1-10
Africa1-10

Index of contact profiles from Ayala Pharmaceuticals

Hundreds of professionals searching for Ayala Pharmaceuticals have connected with key decision-makers. Join them?
Contact Name
Contact Info
Job Title
HQ Location
12

Former Employees at Ayala Pharmaceuticals

Explore people who held key positions, contributed to Ayala Pharmaceuticals's success, and advanced their careers.

People from Similar Companies in the Manufacturing Industry Located in Israel

Frequently Asked Questions Regarding Ayala Pharmaceuticals Employees

How many employees does Ayala Pharmaceuticals have?
Ayala Pharmaceuticals has 11-50 employees
Who is the CEO of Ayala Pharmaceuticals?
Ayala Pharmaceuticals’s CEO is Anthony Lombardo
Who are Ayala Pharmaceuticals key employees?
Some of Ayala Pharmaceuticals key employees are Gili Hart
Where is Ayala Pharmaceuticals located?
Ayala Pharmaceuticals’s headquarters are located at 4 Oppenheimer St, Rehovot, Central District, Israel
How do I contact Ayala Pharmaceuticals?
Ayala Pharmaceuticals Contact Info: Phone number: +972 83731541 Website: www.ayalapharma.com
What does Ayala Pharmaceuticals do?

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical... trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.Read More

Is Ayala Pharmaceuticals a public company?
Yes, Ayala Pharmaceuticals is a public company and is traded under the symbol ADXS
See more information about Ayala Pharmaceuticals Employees

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.